Evidence map›Paper›PMID 35873049›Full record

ArticleFrontiers in chemistry2022

A Low-Cost Paper-Based Device for the Colorimetric Quantification of Bilirubin in Serum Using Smartphone Technology.

Brittany AuYoung, Akshay Gutha Ravichandran, Divykumar Patel, Nisarg Dave, Achal Shah, Brianna Wronko-Stevens, Franklin Bettencourt, Reshma Rajan, Nidhi Menon

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05457543 (Collection of Blood Products for Use in the Development and Validation of Point-of-Care In Vitro Diagnostic Liver Function Test Devices), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05457543 unknown statusnot on this map

Collection of Blood Products for Use in the Development and Validation of Point-of-Care In Vitro Diagnostic Liver Function Test Devices

TypeobservationalSponsorGroup K Diagnostics Inc.Ran2022 to 2023Enrolled150ConditionsLiver Diseases, Healthy, Liver Cirrhosis, Liver FibrosisArmsAdult
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brittany AuYoungDivision of Product Development, Group K Diagnostics, Philadelphia, PA, United States.
Akshay Gutha RavichandranManufacturing Department, Group K Diagnostics, Philadelphia, PA, United States.
Divykumar PatelManufacturing Department, Group K Diagnostics, Philadelphia, PA, United States.
Nisarg DaveDivision of Product Development, Group K Diagnostics, Philadelphia, PA, United States.
Achal ShahDivision of Product Development, Group K Diagnostics, Philadelphia, PA, United States.
Brianna Wronko-StevensGroup K Diagnostics, Philadelphia, PA, United States.
Franklin BettencourtDivision of Product Development, Group K Diagnostics, Philadelphia, PA, United States.
Reshma RajanDivision of Product Development, Group K Diagnostics, Philadelphia, PA, United States.
Nidhi MenonDivision of Product Development, Group K Diagnostics, Philadelphia, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Total bilirubin values have been used as a potential marker to pre-screen and diagnose various liver-based diseases such as jaundice, bile obstruction, liver cancer, etc. A device known as KromaHealth Kit, composed of paper and an acrylic backbone, is developed to quantify total bilirubin in human serum using image processing and machine learning technology. The biochemical assays are deposited on absorbent paper pads that act as reaction zones when serum is added. A dedicated smartphone app captures images of the colorimetric changes on the pad and converts them into quantitative values of bilirubin. The range of bilirubin concentration that can be quantified using the device ranges from 0.5 mg/dl to 7.0 mg/dl. The precision, limit of detection, interference analysis, linearity, stability, and comparison with a predicate are studied in this paper in accordance with clinical and laboratory standards institute. The results indicate that the KromaHealth Kit can be used as an inexpensive alternative to conventional bilirubin testing in clinical settings. With its level of precision, ease-of-use, long shelf-life, and short turnaround time, it will prove to be invaluable in limited-resource settings.

Indexed as

bilirubindiagnosticsimage processingobject detectionpaper microfluidics

Identifiers

PMID35873049
PMCPMC9301313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.